BP-lowering medication should not be used in normotensive primary prevention population at intermediate CV risk

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
AHA 2024
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
- Shawna Nesbitt, MD
Does taking antihypertensive medication in the evening reduce CV events?
Does taking antihypertensive medication in the evening reduce CV events?
ESC Congress 2024
Does taking antihypertensive medication in the evening reduce CV events?
- Ricky Turgeon, PharmD
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
ACC.24
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
- Akshay S. Desai, MD
Improving postpartum BP control has long-term benefits after hypertensive pregnancy
Improving postpartum BP control has long-term benefits after hypertensive pregnancy
AHA 2023
Improving postpartum BP control has long-term benefits after hypertensive pregnancy
- Paul Leeson, MD